The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Shauna Jardon, PharmD
Advertisement
Articles by Shauna Jardon, PharmD
Advertisement
Latest Updated Articles
SPROUT Trial Highlights Benefits of Apremilast for Pediatric PsoriasisPublished: September 12th 2024 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5
